Itovebi (Inavolisib)

Itovebi (inavolisib) is a kinase inhibitor used along with palbociclib and fulvestrant to treat adults who have HR-positive, HER2-negative breast cancer that has an abnormal PIK3CA gene, and has progressed to nearby tissue or lymph nodes (locally advanced), or other parts of the body (metastatic), and has returned after hormone (endocrine) therapy.

Recommended Dosage: The recommended dosage is 9 mg taken orally once daily, with or without food, until there is evidence of disease progression or unacceptable toxicity. Take tablets at approximately the same time each day. Swallow tablet(s) whole without chewing, crushing, or splitting.

If a dose is missed, take it as soon as possible within 9 hours. After more than 9 hours, skip the dose and take the very next dose at the scheduled time. If a dose is puked, do not take an additional dose on that day and resume the usual dosing schedule the very next day.

Use Inavolisib in combination with palbociclib and fulvestrant. The recommended dosage of palbociclib is 125 mg orally once daily for 21 successive days followed by 7 days without treatment to make a cycle of 28 days. For premenopausal and perimenopausal women, administer LHRH agonist as per the local clinical practice. For men, consider the use of LHRH agonists as per local clinical practice.

• Treatment with Itovebi 3 mg/9 mg may cause high levels of blood sugar. Monitor blood glucose regularly, mainly in diabetic individuals. Let your clinician know that certain symptoms such as frequent urination, excessive thirst, or fatigue immediately for the appropriate management and treatment.
• This therapeutic drug may cause mouth sores or inflammation (stomatitis). In case symptoms such as painful ulcers, redness, or swelling occur, inform your healthcare provider. Consider a soft toothbrush, do not eat spicy foods, and follow recommended oral care routines to reduce discomfort.
• Diarrhea is a commonly reported side effect of this medicinal product. Consume plenty of fluids to prevent dehydration. In case diarrhea becomes serious or persistent, consult your healthcare provider (HCP) immediately for suitable medicine or adjustments to the treatment.
• Inavolisib 3 mg/9 mg can harm an unborn baby. Avoid using this medicine during pregnancy, and ensure relevant contraception while on treatment and for a certain period afterward. Let your healthcare provider (HCP) know if you become pregnant while taking this medicine to evaluate the risks.
• Inavolisib may pass into human breast milk and harm a nursing infant. Not breastfeed during treatment and for a specified time after the final dose. Discuss alternative feeding options with your healthcare provider to ensure infant safety.

What documents are required to import ITOVEBI to India?

Itovebi (inavolisib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ITOVEBI available in India?

Itovebi (inavolisib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Itovebi in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada,
• Europe, and Australia
• Ensuring 100% transparency.

ITOVEBI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ITOVEBI (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Itovebi 3 mg/9 mg tablets price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ITOVEBI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Itovebi®?

Inavolisib is a Generic Name for the trade name drug Itovebi®.

What is the manufacturer's name for Itovebi®?

Itovebi® is manufactured by Genentech, Inc.

Does the FDA approve Itovebi®?

Yes, Itovebi® is approved by the FDA. Date of first approval: October 10, 2024.

What is the dosage and form of Itovebi® supplied?

Itovebi is supplied in Tablets: 3 mg and 9 mg for oral use.

What are the most common side effects of Itovebi®?

The most common side effects of Itovebi® are headache, stomatitis, diarrhea, nausea, rash, decreased appetite, fatigue, COVID-19 infection.

How much does Itovebi® Tablets cost in India?

Prices of Itovebi oral tablets may vary over time because of market dynamics and regulatory changes. To know the recent and accurate details on Itovebi 3 mg/9 mg tablets cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Itovebi® Tablets be available in SAARC countries?

Apart from Gulf countries, Itovebi® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Itovebi® tablets in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Itovebi® Tablets online in India?

Yes, one can buy Itovebi 3 mg/9 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Itovebi® oral tablets through legal channels.

What are the storage conditions of Itovebi® Tablets?

Store Itovebi® oral tablets at 20-25°C (68-77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F).